-
.jpg)
.jpg)
- AACR 2021 POSTER
- Comprehensive preclinical study on GI-101, a novel CD80-IgG4-IL2 variant protein, as a therapeuticantibody candidate with bispecific immuno-oncology target
-
.jpg)
.jpg)
- AACR 2020 POSTER
- GI101, A novel CD80-IgG4-IL2 variant bispecific protein, inhibits tumor growth and induces anti-tumor immune response in multiple preclinical models
-
.jpg)
.jpg)
- ESMO 2019 POSTER
- GI101, a novel triple-targeting bispecific CD80-IgG4-IL2 variant fusion protein, elicits synergistic anti-tumor effects in preclinical models
-
.jpg)
(0).jpg)
- UCARE CONFERENCE 2019 POSTER
- GI-301: a novel long-acting IgE Trap-Fc fusion protein for IgE-mediated allergic diseases
